2126 results found

1. How Focusing on Personal Touch Will Help Your Business Thrive

   • 

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close
   under review  ·  Zintro Support responded

   Hello!
   Thanks so much for your submission. We only feature Zintro members on our blog.. Would you be interested in signing up?

2. gap between the borrowers and lenders expectations

   I think there is some gap between the demand and supply sides... as traditionally during financial crises investors prefer to work with existing customers/projects/activities... while there is huge demand for debt/equity investment... but demand side cant get what they expect...
   Simply because there is lower trust on the borrowers... during this period... and instead of getting their loans/investments they get a number of unsuitable options from lenders which cant meet their expectations... and there are a lot of scammers between them who diminish such trust with upfront payments requirements... Zintro can be a good platform to improve communication between these sides to make successful deal between them also to earn its income... Angel investors are also doing not well.. in such aspect... Borrowers ask money and then lenders also ask them pay a lot of money before they can get anything... this aggravates the borrowing process... Zintro can work on such direction to build a good communication between the borrowers and lenders... and such labor can be well paid by both sides... at least by borrowers.. I can continue this discussion... My email is bahmanaskerov@yandex.ru Regards

   I think there is some gap between the demand and supply sides... as traditionally during financial crises investors prefer to work with existing customers/projects/activities... while there is huge demand for debt/equity investment... but demand side cant get what they expect...
   Simply because there is lower trust on the borrowers... during this period... and instead of getting their loans/investments they get a number of unsuitable options from lenders which cant meet their expectations... and there are a lot of scammers between them who diminish such trust with upfront payments requirements... Zintro can be a good platform to improve communication between these… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

3. Selling in the Nano-Second/I Know more than you Culture….

   • 

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

4. The Intersection Between Claim Management and Bad Faith

   • 

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

5. A Tale of Two Clinical Diagnostic Companies by Ken_Powell

   Quest Diagnostics and LabCorp are the two largest commercial reference labs (CRLs) in the US. CRLs are an essential component in healthcare delivery, providing vital routine and esoteric clinical diagnostic test results to physicians, hospitals and numerous alternate site market segments. Since over 70% of all clinical decisions are made on the basis of a diagnostic test result, the value of clinical diagnostic testing in the healthcare continuum speaks for itself.

   Last week LabCorp reported 3 percent revenue growth for Q3. Q3 revenues were $1.46 billion versus $1.42 billion in 2012. Contrast this against an almost 2% revenue drop at Quest, with the top line falling from $1.82 billion in Q3 2012 to $1.79 billion for the same period this year. What’s going on with two virtually identical but very different CRLs? Both CEOs cite reimbursement challenges, particularly in the molecular diagnostics business, government payment reductions and test utilization as growth restrictors.

   What’s in the future for the two largest CRLs in the world and are there other companies in the mix? LabCorp appears to be well positioned for delivering on expectations of 3% annual growth, while Quest guided 2013 revenue performance to 3.5% below 2012. Clearly these are two functionally different companies competing against each other in a highly competitive business, but there are other players such as Bio-Reference Labs, Inc. that present attractive opportunities for investors.

   For more information on the companies mentioned above, the commercial reference lab market and the $52 billion dollar global clinical diagnostic industry, please contact through Zintro and schedule an individual consult today.

   Quest Diagnostics and LabCorp are the two largest commercial reference labs (CRLs) in the US. CRLs are an essential component in healthcare delivery, providing vital routine and esoteric clinical diagnostic test results to physicians, hospitals and numerous alternate site market segments. Since over 70% of all clinical decisions are made on the basis of a diagnostic test result, the value of clinical diagnostic testing in the healthcare continuum speaks for itself.

   Last week LabCorp reported 3 percent revenue growth for Q3. Q3 revenues were $1.46 billion versus $1.42 billion in 2012. Contrast this against an almost 2% revenue drop at… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

6. Clinical Labs Cut Costs but Face Future Challenges by Ken_Powell

   Taking a play from many healthcare payer playbooks, hospital labs have instituted cost cutting and proactive screening programs that yield substantial bottom line benefits. Copying third party payer pre-certification programs for high-cost tests, a Florida healthcare system initiated an esoteric test approval program for any request in excess of $1,000. The result of this program was an annual savings of $220,000. The lab then went on to introduce and monitor test formularies designed to reduce the volume of send out tests to commercial labs. This saved $74,000 and utilizing “best practices” for blood products added another $412,000 in savings.

   But less is not always more. A 248 bed New York Hospital implemented rapid molecular diagnostic testing for hospital acquired infections (HAIs) that reduced the annual rate of C. difficile by 63%, which translated in a cost avoidance of $1.5 million dollars. A great return on a relatively small investment of $86,000 dollars. Mather Memorial Hospital, also in New York followed the same path for a different HAI, Methicillin-resistant Staph aureus (MRSA). Mather’s lab spent $440,000 in new rapid molecular testing to yield a $2 million dollar overall and $1.5 million dollar net savings.

   But the need to decrease costs in the face of rising volumes, payer reimbursement reductions and a serious shortage of qualified medical technologists will continue for the foreseeable future. Considering that over 70% of all clinical decisions are made based on a laboratory test result, the value of laboratory services in the healthcare delivery continuum is essential to overall cost-effective medicine.

   For more information on the $52 billion dollar global clinical diagnostics market segments, opportunities and companies, please contact me through Zintro and schedule an individual consult today.

   Taking a play from many healthcare payer playbooks, hospital labs have instituted cost cutting and proactive screening programs that yield substantial bottom line benefits. Copying third party payer pre-certification programs for high-cost tests, a Florida healthcare system initiated an esoteric test approval program for any request in excess of $1,000. The result of this program was an annual savings of $220,000. The lab then went on to introduce and monitor test formularies designed to reduce the volume of send out tests to commercial labs. This saved $74,000 and utilizing “best practices” for blood products added another $412,000 in savings.

   But… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

7. Insurers Initiate Preauthorization Programs for Genetic Tests by Ken_Powell

   In an effort to control the rapidly escalating costs and inappropriate use of expensive genetic tests, Cigna (NYSE: CI) has implemented a program requiring genetic counseling and pre-authorization for select genetic tests. Other insurers such as Aetna have also instituted such programs after studies have shown that up to 50% or more of the genetic tests ordered by physicians.

   The market for these and other esoteric tests is already larger and expected to become the largest segment of the $52 billion dollar global In Vitro Diagnostic (IVD) industry. Back in 2010, United health (NYSE: UNH) conducted a study that found that spending on genetic testing was approximately $5 billion annually. United health forecasted that by 2020, annual spending on genetic testing would reach $25 billion at its current growth rate. Since the overall IVD market is growing at 6-7% per year, the payers in this space saw a need to curb the unrestrained growth of expensive genetic testing.

   For more information on the strategies employed by payers and users of genetic tests, the regulatory and reimbursement issues surrounding them and companies competing in this high growth market segment, please contact me through Zintro and schedule an individual consult today.

   In an effort to control the rapidly escalating costs and inappropriate use of expensive genetic tests, Cigna (NYSE: CI) has implemented a program requiring genetic counseling and pre-authorization for select genetic tests. Other insurers such as Aetna have also instituted such programs after studies have shown that up to 50% or more of the genetic tests ordered by physicians.

   The market for these and other esoteric tests is already larger and expected to become the largest segment of the $52 billion dollar global In Vitro Diagnostic (IVD) industry. Back in 2010, United health (NYSE: UNH) conducted a study that found… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

8. US-Swiss Agreement Puts Swiss Banks and US Non FBAR Filers at great risk!

   On August 29, 2013 we posted Swiss Banks Agree to Plan to End Past US Tax Evasion Issues! where we discussed that the Swiss banks were ready to pay hefty fines for sheltering United States tax fugitives under the terms of a new deal given the green light by the Swiss government. t reflects the long-standing desire of the US to end the decades-long practice of Swiss banks, supported by their government, of providing safe haven for US tax evaders through a wall of secrecy and a “don’t ask, don’t tell” policy.

   Now the details of this agreement are coming to light. The US-Swiss agreement takes the form of a plea agreement as signified by its name, “Program for Non-Prosecution Agreements or Non-Target Letters for Swiss Banks.” It was signed for the United States by the US Department of Justice, not by the US Treasury Department, implying that US scrutiny of Swiss banks has progressed from tax matters to prosecution concerns.

   On August 29, 2013 we posted Swiss Banks Agree to Plan to End Past US Tax Evasion Issues! where we discussed that the Swiss banks were ready to pay hefty fines for sheltering United States tax fugitives under the terms of a new deal given the green light by the Swiss government. t reflects the long-standing desire of the US to end the decades-long practice of Swiss banks, supported by their government, of providing safe haven for US tax evaders through a wall of secrecy and a “don’t ask, don’t tell” policy.

   Now the details of this agreement are coming… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

9. Vermillion and Quest Diagnostics Part Ways by Ken_Powell

   Vermillion has long struggled with its OVA1 In Vitro Diagnostics Multi-Variant Index Assay (IVDMIA) for ovarian cancer. OVA1 is one of a handful of FDA approved IVDMIAs and was predicted to have a much greater market presence than actually occurred, despite its partnership with Quest Diagnostics, the largest commercial reference lab in the US. Now, Vermillion announced that the company has terminated its licensing agreement with Quest for OVA1 and Vasclir diagnostic tests. CEO Thomas McLain said that following the termination of their long standing relationship, Vermillion would be able to offer OVA1 through other reference labs and gain greater market penetration and revenues.

   This remains to be seen as Vermillion faces not only marketing challenges but reimbursement ones as well. Vermillion is facing significant challenges from the changing regulatory and reimbursement environments in the US, noting, especially an April ruling by BlueCross BlueShield's Technical Evaluation Center that classified OVA1 as "experimental/investigational." This ruling led to 10 BCBS plans reversing their positive coverage decisions for OVA1. This ruling led to 10 BCBS plans reversing their positive coverage decisions for OVA1.

   The American Cancer Society estimates that 21,600 new cases of ovarian cancer will be diagnosed in 2009 and 14,600 women will die from the disease. Ovarian cancer is referred to as the "silent killer" because it is difficult to detect at early, curable stages. CA-125, a biomarker for ovarian cancer has long been used to diagnose this disease along with ultrasound. However, studies have shown that they do not reliably detect ovarian cancer at curable stages.

   For more information on IVDMIAs, Laboratory Developed Tests (LDTs), regulatory issues and the $50 billion dollar global clinical diagnostic market and segments, please contact me through Zintro today to schedule an individual discussion.

   Vermillion has long struggled with its OVA1 In Vitro Diagnostics Multi-Variant Index Assay (IVDMIA) for ovarian cancer. OVA1 is one of a handful of FDA approved IVDMIAs and was predicted to have a much greater market presence than actually occurred, despite its partnership with Quest Diagnostics, the largest commercial reference lab in the US. Now, Vermillion announced that the company has terminated its licensing agreement with Quest for OVA1 and Vasclir diagnostic tests. CEO Thomas McLain said that following the termination of their long standing relationship, Vermillion would be able to offer OVA1 through other reference labs and gain greater… more

   1 vote

   Vote Vote Vote

   Vote

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

   1 vote 2 votes 3 votes Remove votes

   You have left! (?) (thinking…)
   0 comments  ·  Edit…  ·  Delete…  ·  Admin →
   How important is this to you?

   Not at all You must login first! Important You must login first! Critical You must login first!

   We're glad you're here

   Please sign in to leave feedback

   Signed in as (Sign out)

   Close

   Close

10. Members of Congress Join Laboratory Developed Test Controversy by Ken_Powell

    Nine Democratic Representatives are urging the Obama Administration to release the FDA’s draft guidance on the regulation of Laboratory Developed Tests (LDTs).

    A letter sent to Sylvia Mathews Burwell, the Director of the Office of Management and Budget said that the development and widespread use of advanced diagnostics require that the FDA move its guidance forward to “ensure the appropriate and efficient oversight of safe and effective diagnostics”. The legislators further wrote that the lack of FDA oversight “could put patients at safety risks without the FDA’s assurance that the tests (LDTs) are effective.

    Molecular diagnostics is one of the fastest growing segments of the $52 billion dollar global In Vitro Diagnostics (IVD) industry. While many molecular diagnostic tests have been approved by the FDA, there are an estimated 3,000 LDTs that have not. A national registry of LDTs does not exist at the present time. Should the FDA decide to move forward and “set its sights on regulating LDTs” as stated by FDA Commissioner Margret Hamburg last June, several major IVD players could be impacted.

    For more information on LDTs, issues and potential impact please contact me through Zintro and schedule an individual discussion.

    Nine Democratic Representatives are urging the Obama Administration to release the FDA’s draft guidance on the regulation of Laboratory Developed Tests (LDTs).

    A letter sent to Sylvia Mathews Burwell, the Director of the Office of Management and Budget said that the development and widespread use of advanced diagnostics require that the FDA move its guidance forward to “ensure the appropriate and efficient oversight of safe and effective diagnostics”. The legislators further wrote that the lack of FDA oversight “could put patients at safety risks without the FDA’s assurance that the tests (LDTs) are effective.

    Molecular diagnostics is one of the… more

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

11. CULTURAL INTELLIGENCE: The Key to Global Leadership (Zintro id:Nerella)

    • 

    2 votes

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

12. Help, I Need More Members!

    A Great Article on the Importance of a Focused Sales Effort for Membership in Private Country Clubs!

    • 

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    1 comment  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

13. 92% energy saving in retail lighting by introducing LED Technology; Paul-Donegan

    • 

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    1 comment  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

14. "NEED TO DEVELOP NEW BIO-FERTILIZER PRODUCTS CONTAINING MIXED BIO-INOCULUMS"

    The declining trend in pesticide use in agriculture during the 1990s can be attributed to Government of India fiscal policy and technological developments in pest management. Programmes on training of both the extension workers and farmers in the Integrated Pest Management (IPM) were started throughout the country.

    • 

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

15. “Selling Healthcare Services to Employers: Successful Cases”

    BRIEF SUMMARY: The hospital / health system / provider have many diverse options for providing health services directly to area employers. In this article we examine several examples of health systems that created distinct and profitable programs and are successfully selling to employers. The session will explore what employers are looking for from services providers, how to pursue the business, common pitfalls to avoid, and what you can expect in given timeframes. Build relationships with employers, and increase program profits and down-stream revenues.

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

16. Cleantech in the Supply Chain

    The importance of environmental sustainability in the supply chain and its impact on small business.

    • 

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

17. Cheap business class flight tickets

    Book Business Class Flights. Airline tickets for business class generous experience and deals. Plan a trip in business class. Call us for 24/7 Booking. Please call us at (800) 683-0266.
    visit us for more information about cheap flights ticket:- https://www.airowings.com/deals/cheap-business-flights-airline-tickets

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

18. How do I get in touch with a Cash App support agent?

    It is advised that you get in touch with customer service every time you have a query concerning the Cash App. Thankfully, there are various ways to get in touch with the business. You can reach Cash App by calling their toll-free number, using their app, or visiting their website.

    Is customer assistance for the Cash APP available 24/7?

    Calling 1 (800) 969-1940 from 9:00 a.m. to 7:00 p.m. EST, Monday through Friday, will connect you to Cash App Support.

    Visit cash.app/help to contact Cash App.

    You can get in touch with Cash App support through the app or the website if you have issues with the app. They can ask you for some fundamental details, such as your email address. The business is also open to discussing problems with payments. Response times, however, are frequently fast. You might need to get in touch with Cash App support more than once if you run into problems.

    Cash App has a Twitter account and a Facebook page. By downloading the Cash App and participating in the Super Cash App Friday contest, you can win money.

    Use the mobile app to get in touch with Cash App.

    A great way to get in touch with Cash App Support is through a mobile app. This is a great method to get in touch with them without the fuss of email. Additionally, the business has a Twitter account and a Facebook page. Additionally, they are helpful on social media and provide prompt customer service.
    To get in touch with Cash App Support through the mobile app, you need to have a Cash App account. You can make a new account if you are unable to access your old one. On the website, you can contact Cash App Support as well.

    A mobile app called Cash App lets you send and receive money. The programme also allows you to share costs. You should be cautious when sending money to strangers, though. There are a few con games that could be harmful. Scammers might attempt to get you to create an account so they can access your personal data. They might also try to use your card to make purchases.

    For More: https://justtech.help/cash-app-support-number/

    It is advised that you get in touch with customer service every time you have a query concerning the Cash App. Thankfully, there are various ways to get in touch with the business. You can reach Cash App by calling their toll-free number, using their app, or visiting their website.

    Is customer assistance for the Cash APP available 24/7?

    Calling 1 (800) 969-1940 from 9:00 a.m. to 7:00 p.m. EST, Monday through Friday, will connect you to Cash App Support.

    Visit cash.app/help to contact Cash App.

    You can get in touch with Cash App support through the app or the… more

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

19. What is a Gojek Clone App?

    Gojek clone app is a ready-made on-demand app script that can be used by any individual to build and launch their online on-demand business. The best thing about the Gojek clone app (also known as the Gojek clone script) is that it can be used to operate more than 52 businesses at the same time.

    For more info: https://www.apporio.com/product/gojek-clone-app

    •  

    3 votes

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

20. Using routerlogin.net for network setup

    The network setting for your Netgear router can be configured using the default web setup wizard that is accessible using the routerlogin.net web address. Once you have connected your computer/wireless device to the router's network, you use the web address to reach the login page and subsequently the setup wizard as well. The setup wizard will then walk you through the online instructions to complete the network and device setup easily.
    https://nighthawkax.net/

    •  

    1 vote

    Vote Vote Vote

    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close

    1 vote 2 votes 3 votes Remove votes

    You have left! (?) (thinking…)
    0 comments  ·  Edit…  ·  Delete…  ·  Admin →
    How important is this to you?

    Not at all You must login first! Important You must login first! Critical You must login first!

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    Close

    Close